• LAST PRICE
    300.9700
  • TODAY'S CHANGE (%)
    Trending Up2.3500 (0.7870%)
  • Bid / Lots
    300.9700/ 2
  • Ask / Lots
    301.1000/ 3
  • Open / Previous Close
    298.4900 / 298.6200
  • Day Range
    Low 296.5575
    High 301.9800
  • 52 Week Range
    Low 218.4400
    High 329.7200
  • Volume
    533,057
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 298.62
TimeVolumeAMGN
09:32 ET26685298.16
09:34 ET2517298.28
09:36 ET2177299.17
09:38 ET4266298.64
09:39 ET3344298.53
09:41 ET2256297.9
09:43 ET3516297.58
09:45 ET2970297.68
09:48 ET5200297.275
09:50 ET5297296.95
09:52 ET13700297.535
09:54 ET4069297.96
09:56 ET1078297.62
09:57 ET1605297.24
09:59 ET4465297.83
10:01 ET5269297.335
10:03 ET2190297.96
10:06 ET4410297.76
10:08 ET10612297.61
10:10 ET1100297.6
10:12 ET3702296.82
10:14 ET288297.25
10:15 ET600297.66
10:17 ET1968298.07
10:19 ET700298.31
10:21 ET2567298.59
10:24 ET1830299.14
10:26 ET4709299.7
10:28 ET3057299.92
10:30 ET2247299.675
10:32 ET1135299.42
10:33 ET1022299.4
10:35 ET2653298.945
10:37 ET908299.7
10:39 ET2062299.59
10:42 ET947299.805
10:44 ET1420299.8
10:46 ET1746299.67
10:48 ET2131299.3841
10:50 ET3406299.56
10:51 ET367299.55
10:53 ET1700299.8763
10:55 ET1057300.1
10:57 ET2711300.475
11:00 ET5240300.47
11:02 ET5011300.58
11:04 ET783300.925
11:06 ET4400301.22
11:08 ET1652301.0075
11:09 ET4958301.2287
11:11 ET1210301.13
11:13 ET800301.15
11:15 ET1288301.375
11:18 ET4396301.4
11:20 ET3454301.51
11:22 ET1806301.49
11:24 ET1932301.375
11:26 ET1566301.285
11:27 ET810301.33
11:29 ET800301.39
11:31 ET1302301.33
11:33 ET1049301.045
11:36 ET9093301.189
11:38 ET7036301.395
11:40 ET2001301.2
11:42 ET755301.08
11:44 ET2500301.29
11:45 ET854301.21
11:47 ET500301.15
11:49 ET2428300.88
11:51 ET200300.85
11:54 ET1621300.72
11:56 ET1127300.7843
11:58 ET1200301.17
12:00 ET1400300.9
12:02 ET1801301.06
12:03 ET855301.175
12:05 ET3000301.11
12:07 ET4690300.82
12:09 ET1110300.975
12:12 ET1800301.24
12:14 ET527301.1753
12:16 ET732301.162
12:18 ET3000300.82
12:20 ET400300.595
12:21 ET892300.62
12:23 ET2851300.94
12:25 ET2708301.265
12:27 ET1782301.31
12:30 ET4940301.8
12:32 ET3570301.74
12:34 ET2526301.9364
12:36 ET2754301.75
12:38 ET2470301.79
12:39 ET1867301.72
12:41 ET2401301.3601
12:43 ET4464301.42
12:45 ET1425301.18
12:48 ET1209301.16
12:50 ET2631301.25
12:52 ET2651301.18
12:54 ET1200300.99
12:56 ET832300.97
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAMGN
Amgen Inc
160.2B
43.0x
-0.22%
United StatesGILD
Gilead Sciences Inc
81.1B
179.7x
+1.53%
United StatesHLN
Haleon PLC
37.8B
28.2x
---
United StatesGSK
GSK plc
84.9B
14.6x
+6.39%
United StatesBMY
Bristol-Myers Squibb Co
83.5B
-13.2x
+4.90%
United StatesPFE
Pfizer Inc
156.0B
-443.4x
-7.10%
As of 2024-06-17

Company Information

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine), KYPROLIS (carfilzomib), Maridebart cafraglutide, (infliximab-axxq), Evenity, LumaKras, Nplate and XGeva, others.

Contact Information

Headquarters
One Amgen Center DriveTHOUSAND OAKS, CA, United States 91320
Phone
805-447-1000
Fax
805-447-1010

Executives

Chairman of the Board, President, Chief Executive Officer
Robert Bradway
Chief Financial Officer, Executive Vice President
Peter Griffith
Executive Vice President, Chief Technology Officer
David Reese
Executive Vice President, Research and Development, and Chief Scientific Officer
James Bradner
Executive Vice President, General Counsel, Secretary
Jonathan Graham

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$160.2B
Revenue (TTM)
$29.5B
Shares Outstanding
536.4M
Dividend Yield
2.99%
Annual Dividend Rate
9.0000 USD
Ex-Dividend Date
05-16-24
Pay Date
06-07-24
Beta
0.58
EPS
$7.00
Book Value
$11.64
P/E Ratio
43.0x
Price/Sales (TTM)
5.4
Price/Cash Flow (TTM)
19.2x
Operating Margin
23.92%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.